Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (2 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (5)
Guidance programme
Guidance programme
Technology appraisal guidance (5)
Apply filters
Showing 1 to 5 of 5
Sort by
Date
Title
Apply sorting
Keyword or reference number: cetuximab
`Remove $Keyword or reference number: cetuximab filter`
Type: Guidance
`Remove $Type: Guidance filter`
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Encorafenib plus
cetuximab
for previously treated BRAF V600E mutation-positive metastatic colorectal cancer
TA668
6 January 2021
6 January 2021
Cetuximab
and panitumumab for previously untreated metastatic colorectal cancer
TA439
29 March 2017
25 September 2017
Cetuximab
for treating recurrent or metastatic squamous cell cancer of the head and neck
TA473
31 August 2017
31 August 2017
Cetuximab
, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy
TA242
25 January 2012
25 January 2012
Cetuximab
for the treatment of locally advanced squamous cell cancer of the head and neck
TA145
25 June 2008
25 June 2008
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top